Experience with rubella vaccines in the U.S.A., 1969-1971.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000914:Antibodies, Viral; D002648:Child; D002675:Child, Preschool; D004285:Dogs / Q000276:immunology; D004372:Ducks; D004622:Embryo, Mammalian / Q000276:immunology; D004625:Embryo, Nonmammalian; D005260:Female; D005333:Fetus / Q000276:immunology; D005865:Gestational Age; D000882:Haplorhini; D006801:Humans; D007111:Immunity, Cellular; D007223:Infant; D007231:Infant, Newborn; D007592:Joint Diseases / Q000209:etiology; D010146:Pain; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000517:prevention & control; D011314:Preventive Health Services; D011817:Rabbits / Q000276:immunology; D012008:Recurrence; D012409:Rubella / Q000151:congenital / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000009:adverse effects; D013997:Time Factors; D014481:United States; D014611:Vaccination
D000914:Antibodies, Viral; D012411:Rubella Vaccine